ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGY Allergy Therapeutics Plc

2.85
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.85 2.80 2.90 2.85 2.85 2.85 360,349 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 59.59M -43.07M -0.0090 -3.17 135.84M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 2.85p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 0.85p to 3.80p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £135.84 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -3.17.

Allergy Therapeutics Share Discussion Threads

Showing 2776 to 2797 of 5000 messages
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older
DateSubjectAuthorDiscuss
24/6/2014
19:09
Cube
Thanks
jl

jimmyloser
24/6/2014
10:27
That would be useful, there's been a lot of loyalty shown to this stock for several years now and I think people need to start seeing not just the right words but some right actions too.
aruntim
24/6/2014
10:00
Going to phone IP later, see if I can get anything out of him! don't expect any Price sensitive info, but just a little reassurance all is on track!
Will let you know Jimmy and all. Need some kind of update..:0))

cube boss
23/6/2014
09:55
Our biggest market - currently!
jimmyloser
18/6/2014
13:42
European Patent Granted For MPL-Based Sublingual Vaccines

Allergy Therapeutics (AGY), the specialist pharmaceutical company focused on allergy vaccination, announces that the European Patent office has granted a broad technology patent relating to the Company's family of MPL®-based sublingual allergy vaccines. This patent (jointly held with Corixa Inc) covers the use of glycolipid adjuvant administered sublingually with one or more antigens for use in the treatment of allergy or other diseases (infections, cancer or autoimmunity).

Allergy Therapeutics' new generation of allergy vaccines use MPL®, an innovative TLR4-agonist, as an adjuvant to boost and accelerate the immune response of an allergy vaccine. Allergy Therapeutics has already conducted and previously reported results of a double-blind, placebo controlled, dose ranging Phase IIa MPL-based oral allergy vaccine study. The study (Study 103) was conducted in 80 grass-sensitive human subjects and involved the addition of MPL to Allergy Therapeutics' ORALVAC® grass pollen vaccine. This was the first time that any adjuvant had ever been clinically tested in an oral allergy vaccine and was also the first ever examination of oral delivery of MPL in humans. The results demonstrated that the vaccine was well tolerated and that, following an eight week treatment period, clinical symptoms improved and were accompanied by a characteristic pattern of immune response.

Datamonitor estimates that the prevalence of allergic rhinitis ("AR") varies from 9.2% (Germany) to 17.2% (FRANCE) and that in the five major European markets the diagnosed AR population over 20 years of age is 28.3 million. However, under-diagnosis is substantial, with an estimated 44% of the AR population not diagnosed1. The value of the immunotherapy market in Europe is estimated to be more than €550 million.

The development of a convenient, effective, short course, well tolerated oral allergy vaccine would have significant implications for allergy therapy and redefine the market for allergy products. Currently available oral allergy vaccines require prolonged treatment periods associated with poor patient compliance and low efficacy.

jimmyloser
18/6/2014
09:36
A Market that they should be addressing
moneyman18
17/6/2014
19:08
???????????????

from where we came is where we'll rest

??????????????

jimmyloser
15/6/2014
12:13
Hopefully though not "glowing in the dark".
algernon2
13/6/2014
10:33
Need to walk the Dog Cube its a duster.(TRP).
Guess we'll see you back on here more now?

algernon2
04/6/2014
16:46
Good news in Germany on birch testing

Relax - this is slow burn but behaving well.

impo/dyor

jimmyloser
04/6/2014
15:01
Can we please just shot up to 45p within the next six weeks, I'd rather relax a little more on my holiday!
aruntim
04/6/2014
14:33
Do we have any diary dates/events scheduled for AGY?

FG

farmer george
04/6/2014
14:05
Hay fever really bad this year, Lets HOPE AGY are cashing in with their products
moneyman18
02/6/2014
12:23
Must have had sleep in my eyes...Lol :0)
cube boss
02/6/2014
08:29
Touch of BLUE this am, am I seeing correctly? May it continue...:0))
cube boss
23/5/2014
17:30
Cube
You and t'dog can come back home now - it worked!

lol

jimmyloser
23/5/2014
09:28
Just setting off now Jimmy! the dog has a great RAIN coat...:0))
Needs news here guys.
Have a great weekend..:0))

cube boss
22/5/2014
21:33
May need to upgrade it a whippet if you do!
aruntim
22/5/2014
18:29
Cube
Any plans to walk the dog tomorrow....Lands End to John O' Groats for instance?

jimmyloser
20/5/2014
14:46
This is swinging on nothing more than intra-day sentiment lol

impo.

jimmyloser
20/5/2014
13:15
are we going to get to buy at 17p
bad robot
19/5/2014
16:10
Stick hold tight - impo/DYOR
jimmyloser
16 May'14 - 15:19 - 2622 of 2659 0 0 edit



jimmyloser
15 May'14 - 07:30 - 2610 of 2621 0 0 edit


Take a closer look and read between the lines.

We have a serious buyer

jimmyloser
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older

Your Recent History

Delayed Upgrade Clock